As filed with the Securities and Exchange Commission on April 3, 2014

 

 

 

Securities and Exchange Commission

Washington, D.C. 20549

 

SCHEDULE TO

 

Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

 

Morgan Stanley Asia-Pacific Fund, Inc.

(Name of Subject Company [Issuer])

 

Morgan Stanley Asia-Pacific Fund, Inc.

(Name of Filing Persons)

 

Common Stock, Par Value $0.01 Per Share

(Title of Class of Securities)

 

61744U106

(CUSIP Number of Class of Securities)

 

522 Fifth Avenue
New York, New York 10036

(Address of Principal Executive Office)

 

Telephone Number, Including Area Code: (212) 296-6969

 

Joseph C. Benedetti, Esq.
522 Fifth Avenue
New York, New York 10036

(Name and Address of Agent for Service)

 


 

Copy to:

 

Carl Frischling, Esq.
Kramer Levin Naftalis & Frankel LLP
1177 Avenue of the Americas
New York, New York 10036

 

Stuart M. Strauss, Esq.
Dechert LLP
1095 Avenue of the Americas
New York, New York 10036

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of the Person(s) Filing
Statement)

 

Calculation of Filing Fee

 

Transaction Valuation

 

Amount Of Filing Fee

$62,552,525(a)

 

$8,057(b)

 


(a)

 

Estimated for purposes of calculating the amount of the filing fee only. Pursuant to Rule 0-11(b)(1) under the Securities Exchange Act of 1934, as amended, the Transaction Value was calculated by multiplying 3,502,381 shares of common stock of the Fund (20% of the total number of shares outstanding on March 3, 2014) by $17.86 (98.5% of the net asset value per share of $18.13 as of the close of regular trading on the New York Stock Exchange on March 3, 2014 ).

(b)

 

Calculated at $128.80 per $1,000,000 of the Transaction Value.

 

 

 

x

 

Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

Amount Previously Paid: 8,057

 

Filing Party: Morgan Stanley Asia-Pacific Fund, Inc.

Form or Registration No.: Schedule TO

 

Date Filed: March 6, 2014

 

o

 

Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

o

 

third party tender offer subject to Rule 14d-1.

 

 

 

x

 

issuer tender offer subject to Rule 13e-4.

 

 

 

o

 

going-private transaction subject to Rule 13e-3.

 

 

 

o

 

amendment to Schedule 13D under Rule 13d-2.

 

Check the following box if the filing is a final amendment reporting the results of the tender offer.   o

 

 

 



 

Introductory Statement

 

This Amendment No. 1 amends and supplements the Tender Offer Statement on Schedule TO originally filed by Morgan Stanley Asia-Pacific Fund, Inc. (the “Fund”) with the Securities and Exchange Commission (the “Commission”) on March 6, 2014 to add an additional exhibit in accordance with Rule 13e-4(c)(1) promulgated under the Securities Exchange Act of 1934, as amended.

 

The information in the Issuer Tender Offer Statement and the related Letter of Transmittal is incorporated herein by reference in answer to Items 1 through 11 required to be disclosed in this Schedule TO.

 

Item 12.  Exhibits.

 

(a)(1)(i)

 

Issuer Tender Offer Statement, dated March 6, 2014.*

(a)(1)(ii)

 

Form of Letter of Transmittal.*

(a)(1)(iii)

 

Form of Notice of Guaranteed Delivery.*

(a)(1)(iv)

 

Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.*

(a)(1)(v)

 

Form of Letter to Clients of Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.*

(a)(1)(vi)

 

Form of Letter to Stockholders.*

(a)(2)

 

None.

(a)(5)

 

Text of press release dated and issued on March 6, 2014.*

(a)(6)

 

Text of press release dated and issued on April 3, 2014. (filed herewith)

(b)

 

None.

(d)

 

None.

(g)

 

None.

 


* Previously filed as an exhibit to the Schedule TO filed by the Fund with the Commission on March 6, 2014.

 

Item 13.  Information Required by Schedule 13E-3.

 

Not applicable.

 

2



 

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

MORGAN STANLEY ASIA-PACIFIC FUND, INC.

 

 

 

 

 

/s/ Joanne Antico

 

Name: Joanne Antico

 

Title: Assistant Secretary

 

 

Dated: April 3, 2014

 

 

3


Abattis Bioceuticals (CE) (USOTC:ATTBF)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Abattis Bioceuticals (CE) Charts.
Abattis Bioceuticals (CE) (USOTC:ATTBF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Abattis Bioceuticals (CE) Charts.